AI tool designed to predict breast cancer recurrence cleared by FDA
The tool analyzes previously collected breast MRI scans to estimate the risk of recurrence five and 10 years after diagnosis., The tool analyzes previously collected breast MRI scans to estimate the risk of recurrence five and 10 years after diagnosis., from Newsnation Read MoreContinue Reading












